Down-regulation of CDC25C can induce cell cycle arrest at the G2/M phase, and its abnormal expression is associated with cancer initiation, development, metastasis and poor prognosis (Ozen and Ittmann 2005; Ying et al. 2018). Here, CDC25C is linked to cancer.